Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PREDICT Gives FDA Head Start On Meeting House's Call For "Trade Facilitation"

Executive Summary

FDA's PREDICT system should enable the agency to comply with the intent, if not the particulars, of a House Appropriations Committee suggestion to facilitate entry into the United States of goods that pose little risk.

You may also be interested in...



Adjuvanted Flu Vaccines Get Booster: House Report Presses FDA On Approval

House appropriators are pressing FDA to license adjuvanted seasonal influenza vaccines that have a proven safety record.

Separate FDA Safety Office Attached To House Report, Still Faces Steep Road

A proposal to establish an independent post-market drug surveillance office at FDA will face tough sledding if it comes up in the House Energy and Commerce Health Subcommittee.

House Approps Bill Would "Harden" Science Requirements For FDA Rules, Guidance

Provision meant to protect ranchers/farmers could unleash Pandora's box of impediments to regulations, guidance; panel debates Avastin.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS053466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel